؉ channel) proteins play critical functional roles in heart and brain physiology. Using antibodies directed to either GIRK1 or GIRK4, site-directed mutagenesis, and specific glycosidases, we have investigated the effects of glycosylation in the biosynthesis and heteromerization of these proteins expressed in oocytes. Both GIRK1 and GIRK4 have one extracellular consensus N-glycosylation site. Using chimeras between GIRK1 and GIRK4 as well as a GIRK1 N-glycosylation mutant, we report that GIRK1 was glycosylated at Asn 119 , whereas GIRK4 was not glycosylated at Asn 132 . GIRK1 membrane-spanning domain 1 was required for optimal glycosylation at Asn 119 because a chimera that contained GIRK4 membrane-spanning domain 1 significantly reduced the addition of a carbohydrate structure at this site. This finding may partly account for the reason that GIRK4 is not glycosylated at Asn 132 , either as a homomer or when coexpressed with GIRK1. When the GIRK1(N119Q) mutant was coexpressed with GIRK4, the biophysical properties of the heteromeric channel and the magnitude of the agonist-induced currents were similar to those of controls. Thus, N-glycosylation of GIRK1 at Asn 119 does not appear to affect its physical association with GIRK4, the routing of the heteromer to the cell surface, or heteromeric channel function, unlike the dramatic functional effects of N-glycosylation of ROMK1 at Asn 
Glycosylation of plasma membrane proteins is a common post-translational modification that is thought to be important for protein folding in internal organelles and, in some cases, membrane targeting and function (1) . Most ion channels are glycosylated, but the functional role played by this modification varies among these proteins. Studies have presented evidence that glycosylation modifies the function of some ion channels (2) (3) (4) (5) (6) (7) (8) , which suggests that differential glycosylation may be an additional mechanism used by cells to increase channel functional diversity. However, other studies reported no change in channel function when glycosylation was prevented (9, 10) .
Inward rectifier K ϩ channels play important roles in cellular physiology (11, 12) . These channels were first cloned by expression cloning from kidney (ROMK1 or Kir1.1) (13) and a macrophage cell line (IRK1 or Kir2.1) (14) . GIRK (G protein-gated inward rectifier K ϩ channel) proteins were then cloned by homology or by expression cloning from atria, brain, pancreas, and Xenopus: GIRK1 (KGA or Kir3.1) (15, 16) , GIRK2 (Kir3.2) and GIRK3 (Kir3.3) (17) , and GIRK4 (CIR, KGP, or Kir3.4) (Refs. 18 -23 ; reviewed in Ref. 24 ). GIRK1-4 are expressed in brain, and GIRK1 and GIRK4 are expressed in atria. Previous studies have shown that acetylcholine (ACh) 1 activated I K(ACh) in atrial myocytes through muscarinic receptors coupled to pertussis toxin-sensitive GTP-binding proteins (G proteins) (25) (26) (27) . The G␤␥ subunits appear to be the main activator of I K(ACh) (28, 29) . Evidence has also been presented that, in atrial tissue, GIRK1 and GIRK4 form a heteromer and that this association is required for a functional K ACh channel (19) . GIRK1 also forms functional heteromers with GIRK2 or GIRK3 (30) .
N-Glycosylation of the inward rectifier ROMK1 has been reported to modify channel function significantly: the ROMK1(N117Q) mutant exhibited a dramatic reduction in the magnitude of macroscopic currents ascribed to a decrease in the channel open probability (4) . The objective of this study was to investigate the effects of N-glycosylation on GIRK function by determining (a) the GIRK1 and GIRK4 amino acids that are N-glycosylated, (b) if additional channel regions affect glycosylation at these identified sites, and (c) whether glycosylation modifies heteromeric channel expression levels and function in the oocyte system.
EXPERIMENTAL PROCEDURES

Cloning of GIRK1 (Human Brain Kir3.1) and GIRK4 (Human Pancreatic Kir3.4)-GIRK1
and GIRK4 cDNAs were isolated from a human brain and a human pancreatic cDNA library, respectively, as described previously (21) . These constructs will be referred to as GIRK1 and GIRK4.
Construction of cDNA Mutants-Construction of chimeric cDNAs between GIRK4 and GIRK1 has been previously described (31) . An N-glycosylation mutant of GIRK1 (GIRK1(N119Q)) was produced by the polymerase chain reaction method using pGEMHE-GIRK1 as a template and two primer pairs (N119Q forward (GCCCAGGTCGGT-CAGTACACGCCT) and Sp6; N119Q reverse (GCGTGTACTGAC-CGACGTGGGC) and T7). The amplification conditions were 94°C for 1 min, 52°C for 1 min, and 72°C 1.3 min for 22 cycles. The two polymerase chain reaction products were purified and used as templates for the second polymerase chain reaction using primers T7 and Sp6. The amplification conditions were 94°C for 1 min, 50°C for 1 min, and * This work was supported by National Institutes of Health Grants NS29633 (to W. B. T.) and HL54185 (to D. E. L.) and by American Heart Association Grant-in-aid 96011620 (to D. E. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 72°C for 1.3 min for 22 cycles. The purified polymerase chain reaction product was gel-purified, digested with BamHI/EcoRI, and ligated into a pGEMHE vector. The pGEMHE-GIRK1(N119Q) plasmid was propagated and purified using a QIAGEN plasmid column following the vendor's instructions. DNA sequencing confirmed that the mutation had been introduced (Sequenase 2.0 kit, Amersham Pharmacia Biotech).
In Vitro cRNA Production-GIRK1, GIRK4, and human m2 muscarinic receptor cDNAs were subcloned into the pGEMHE vector, which has been modified to produce 5Ј-and 3Ј-untranslated sequences on cRNAs that increase both their translation efficiency and stability. cRNAs were produced by in vitro transcription from appropriate plasmids by standard methods (32) . The cRNA quality was checked on a denaturing agarose gel, and the concentration was determined spectrophotometrically.
Antibody Production and Characterization-A C-terminal peptide to GIRK1 was synthesized and purified, and its amino acid composition was verified using standard methods by Dr. A. Buku (Department of Physiology and Biophysics, Mount Sinai Medical Center). The GIRK1 peptide to the C terminus (amino acids 478 -501, CGPTRMEGNLPA-KLRKMNSDRFT) was attached through a cysteine residue to keyhole limpet hemocyanin, and the conjugates were injected into rabbits for production of Abs. The GIRK1 peptide was covalently attached to Sulfolink Sepharose beads (Pierce), and Abs were affinity-purified via the vendor's protocols. Affinity-purified rabbit polyclonal Abs to GIRK4 (amino acids 2-24, CGGDSRNAMNQDMEIGVTSQDMK) were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). This Ab would be predicted to react with KATP1/CIR/GIRK4. The specificities of Abs against both the anti-GIRK1 C terminus (33) and the anti-GIRK4 N terminus (21) have been determined by immunoblot analysis using membranes from untransfected and transfected cell lines. Only affinitypurified Abs were used in this study.
Production of Xenopus Oocytes and cRNA Injection-Stage V and VI oocytes were isolated and maintained as described (21 35 S]Met/Cys (75% Met and 25% Cys; NEN Life Science Products) for 2-3 days. All of the following steps were carried out with iced solutions or at 5°C. Healthy oocytes were homogenized with a Dounce homogenizer (three strokes) in 2-4 ml of lysis buffer (5 mM Tris-HCl (pH 8), 1 mM EDTA, and 1 mM EGTA with protease inhibitors). Yolk was precleared by centrifuging at 3000 ϫ g for 5 min. The supernatant was then centrifuged at 100,000 ϫ g for 30 min, and the total membrane fraction was solubilized in 1.0 ml of nondenaturing buffer (2% Triton X-100, 50 mM Tris (pH 7.4), and radioimmune precipitation assay SDS-deficient buffer) (34) . Affinity-purified Abs were added (3-5l of Ab/ml) overnight. Protein A beads (Pierce; 50 l of a 1:1 slurry) were added, and the solution was rocked for 1.5 h. The beads were washed three to five times with 1 ml of phosphate-buffered saline. SDS sample buffer (50 l) was added, and the solution was heated to 37°C for 2 min. We and others (Upstate Biotechnology Inc., Lake Placid, NY) have found that inward rectifier K ϩ channel proteins tend to aggregate on SDS gels if they are heated above 37°C even in the presence of SDS (data not shown). The eluted material was run on a 10% SDS gel, and the radiolabeled proteins were visualized by fluorography with XAR5 film (Eastman Kodak Co.). Each experimental condition was repeated at least three times, and the protein profiles on gels were similar.
Glycosidase Treatment of Proteins-Immunoprecipitated radiolabeled channel proteins were treated with glycosidases (0.2 units/ml Endo H and PNGase F, Roche Molecular Biochemicals) overnight at 37°C following the vendor's instructions. Following treatment, samples were denatured in sample buffer and run on 10% SDS gels as described above.
Immunoblotting-Aliquots of crude membranes from oocytes injected with GIRK cRNAs were denatured in sample buffer and run on SDS gels (as outlined above). The proteins were transferred to a nitrocellulose filter (Bio-Rad), and the filter was blocked in 5% nonfat milk in phosphate-buffered saline. Primary antibody (GIRK1 at 1:1000 in 5% nonfat milk/phosphate-buffered saline) was added overnight, and the filters were extensively washed. GIRK1 proteins were visualized by secondary antibody-horseradish peroxidase conjugate using ECL (Amersham Pharmacia Biotech) and XAR5 film.
Two-microelectrode Voltage Clamp and Patch
Clamping of OocytesNon-injected and cRNA-injected oocytes were maintained in complete ND96 medium. As controls, oocytes were also injected with GIRK cRNAs alone or the m2 muscarinic receptor cRNA alone. Oocytes were then studied electrophysiologically 3-5 days following injection (21, 31) . Oocytes were perfused with the standard high K ϩ recording solution (96 mM KCl, 2 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , and 5 mM HEPES (pH 7.4)) in the absence and then presence of ACh (5 M). Microelectrodes were filled with 3 M KCl and had resistances of 0.5-1.0 megaohms. Currents were measured by a conventional two-microelectrode voltageclamp amplifier (World Precision Instruments, Inc., Gene Clamp) and were stored and analyzed on a computer using pCLAMP Version 6.01 software (Axon Instruments, Inc.). All experiments were performed at room temperature (21-25°C). Patch-clamp recordings (35) were performed as described previously (21, 31, 36) . To remove the vitelline membrane, oocytes were placed in a hypertonic solution (37) for 5-10 min. Shrunk oocytes were first transferred to a V-shaped recording chamber, and the vitelline membrane was partially removed, exposing just enough plasma membrane for access with a patch pipette. This procedure increased the success rate of forming gigaseals and reduced automatic detaching in long-term cell-attached recordings.
Single-channel activity was recorded in cell-attached or inside-out patch configurations (35, 38) using an Axopatch 200A amplifier (Axon Instruments, Inc.). All microelectrodes used in the experiments were pulled from World Precision Instruments borosilicate glass and gave resistances of 3-8 megaohms. The pipette solution included 96 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM HEPES (pH 7.35). The bath solution included 96 mM KCl, 5 mM EGTA, and 10 mM HEPES (pH 7.35). 100 M gadolinium was included in the pipette solution to suppress native stretch channel activity in the oocyte membrane. Chemicals were purchased from Sigma. Free Mg 2ϩ and ATP concentrations were estimated as described previously (39) . Single-channel recordings were performed at a membrane potential of Ϫ80 mV and in the absence of agonist in the pipette, unless otherwise indicated. Single-channel currents were filtered at 1-2 kHz with a six-pole low-pass Bessel filter, sampled at 5-10 kHz, and stored directly into the computer's hard disc through the DIGIDATA 1200 interface (Axon Instruments, Inc.). pCLAMP Version 6.01 software were used for data acquisition and data analysis, complemented with an analysis routine of our own. Details of single-channel analysis are described by Sui et al. (36) .
RESULTS AND DISCUSSION
Glycosylation Sites on Inward Rectifier K
ϩ Channels-Hydrophobicity plots of the primary amino acid sequences of inward rectifier K ϩ channels suggest that they have two putative membrane-spanning domains (referred to as M1 and M2) with an extracellular linker containing the pore region (H5), and functional channels have been proposed to be tetramers (13, 14) . Both of these assertions have been strengthened by structural studies on a bacterial potassium channel (40) . GIRK1, GIRK4, and ROMK1 each contain one putative N-glycosylation site (NX(S/T), where X is any amino acid except P (1) at Asn 119 , Asn 132 , and Asn 117 , respectively, in their M1-M2 extracellular linkers (Fig. 1A) . This is the only putative N-glycosylation site on GIRK1, whereas GIRK4 has an additional site at Asn 253 , which is in the putative intracellular C terminus. Immunoblot analysis suggests that GIRK1 is expressed in atrial tissue as both a 67-72-kDa glycosylated protein and a partially or nonglycosylated 56-kDa protein (19) , whereas in brain, it is expressed as a glycosylated 65-kDa protein (33) . Thus, GIRK1 in native tissue contains ϳ9 -16 kDa of carbohydrate/monomer. In contrast, GIRK4 in atrial tissue exhibited the predicted molecular mass of its core polypeptide (45 kDa), and the protein was not glycosylated in a canine rough microsomal system (19) . This finding indicates that its N-glycosylation site is not accessible or in a suitable conformation for attachment of a carbohydrate structure. ROMK1 was N-glycosylated in a canine rough microsomal system as well as when it was expressed in a cell line (4, 13). There are a few putative extracellular O-glycosylation sites (P(S/T), (S/T)P, (S/T)X 1-3 P, or S/T (41, 42)) on GIRK1, GIRK4, and ROMK1.
GIRK1 and GIRK4 Protein Expression-Chimeric cDNAs between GIRK4 and GIRK1 were constructed, and their cRNAs have been functionally characterized in oocytes to examine channel regions that play a role in heteromeric activity (31) . The strategy in this current report was to use these constructs (Fig. 1B) and the oocyte expression system, which both N-and O-glycosylates membrane proteins (43) , to map the region of each channel protein that might contain covalently attached carbohydrate structures. Oocytes were injected with individual and multiple cRNAs for GIRK4, GIRK1, or different mutant constructs and incubated with [ 35 S]Met/Cys to label total proteins. Specific Abs to GIRK1 (G1-Ab) and GIRK4 (G4-Ab) were used to immunoprecipitate solubilized nondenatured channel proteins from total crude membranes. A portion of the immunoprecipitated proteins were digested with glycosidases, and the untreated and treated proteins were then run on SDS gels to determine their pattern and degree of glycosylation. Endo H cleaves only high mannose-type N-linkages (44) . This linkage is found on most immature rough endoplasmic reticulum N-glycosylated proteins and on some mature plasma membrane proteins. In contrast, PNGase F cleaves all N-linkages (high mannose-, hybrid-, and complex-type N-linkages) (44) .
The pattern of G1-Ab-precipitated [ 35 S]Met/Cys-labeled membrane proteins from oocytes injected with the different chimeric cRNAs between GIRK4 and GIRK1 (G4/G1A-E) as well as oocytes coinjected with GIRK4 ϩ GIRK1 (G4ϩG1) cRNAs and their sensitivity to Endo H glycosidase are shown in Fig. 2 (A and B) . G1-Ab did not precipitate any proteins from non-injected oocytes (Fig. 2B, lane 1 ; also see Ref. 21) . A prominent sharp 56-kDa band (p56) was detected in all oocytes injected with channel cRNAs, which is the size expected for the nonglycosylated core polypeptide. Presumably, p56 was inserted into membranes since only the total membrane fraction from oocytes was used. Glycosylated channel proteins would be predicted to run slower than p56. A 58-kDa band (p58) was detected in oocytes injected with G4/G1D cRNA (Fig. 2, A, lane  4; and B, lane 8) , whereas a much more intense p58 was detected in G4/G1E or G4ϩG1 cRNA-injected oocytes (Fig. 2, A,  lane 5; and B, lanes 10 and 12) . p58 was sensitive to Endo H treatment (Fig. 2B, lanes 9, 11, and 13) . A diffuse protein band running slower than p58 was detected in all cRNA-injected oocytes, although at variable intensity (G4/G1A-D Ͻ G4/G1E, G4ϩG1) (Fig. 2, A and B) . This diffuse band will be referred to as ϳp70, and it was not sensitive to Endo H treatment (Fig. 2B,  lanes 3, 5, 7, 9, 11, and 13) . In addition, a 43-kDa band (p43) was precipitated from G4/G1C-E cRNA-injected oocytes ( Fig.  2A, lanes 3-5) , which was not precipitated from non-injected oocytes (Fig. 2B, lane 1) . Moreover, radiolabeled proteins were not precipitated when the antibody was blocked with the specific channel peptide (data not shown). p43 appears to be an endogenous GIRK4-like channel that forms heteromers with GIRK1 (21) , and this channel has been cloned and characterized (23) . In G4ϩG1 cRNA-coinjected oocytes, G1-Ab precipitated a 45-kDa band (p45) that corresponds to the exogenous GIRK4 protein (Fig. 2B, lanes 12 and 13) . This finding, which has been shown previously (21) , indicates that the GIRK1 and GIRK4 proteins physically associate. Both p43 and p45 had the approximate predicted size for their nonglycosylated core proteins, and they were not Endo H-sensitive (Fig. 2B, lanes 7, 9,  11, and 13) .
Results from G4/G1A-E chimeric and G4ϩG1 protein expression in oocytes and their Endo H sensitivity indicate that p56 is a nonglycosylated protein and that p58 is a glycoprotein that contains one high mannose N-linked carbohydrate structure (Fig. 2B, lanes 8 -13) that is attached to GIRK1 between GIRK1 amino acids 108 and 134 (Fig. 1B) . G4/G1E displayed a FIG. 1. GIRK1 and GIRK4 . A, M1-M2 extracellular linker amino acid sequences for three inward rectifier potassium channels: GIRK1 (15), GIRK4 (18) , and ROMK1 (13) . M1, M2, and H5 represent the first and second putative membrane-spanning domain and the putative pore region, respectively. Colons represent amino acid identities to GIRK1, and dashes are spaces to maximize alignment. The putative N-glycosylation sites (NX(S/T)) are underlined. B, schematic diagram of GIRK1 and GIRK4 with the five G4/G1 chimeric constructs (A-E) used in this study. Also depicted are the amino positions for the wild-type channels where chimeric construct junctions were designed. The numbers represent amino acid numbers on GIRK1 or GIRK4.
FIG. 2. Biosynthesis of G4/G1 chimeric proteins and G4؉G1 wild-type proteins in oocytes. Oocytes were injected with 5 ng of different cRNAs and incubated with [
35 S]Met/Cys for 2-3 days. Total crude membranes were isolated from oocytes, and the nondenatured solubilized membrane proteins were immunoprecipitated with G1-Ab (IP-G1-Ab) and protein A beads. The proteins were eluted and run on a 10% SDS gel (five oocytes/lane), and the radiolabeled proteins were visualized by fluorography. Molecular mass standards are shown on the left. The precipitated 35 S-labeled proteins are shown on the right. A, protein pattern in oocytes injected with individual G4/G1 chimeric cRNA. B, glycosidase sensitivity of GIRK proteins. Shown is the protein pattern in oocytes injected as described for A and also coinjected with GIRK4 and GIRK1 cRNAs. The immunoprecipitate was split, and onehalf was treated with Endo H overnight at 37°C (ϩ), whereas the other half was not treated (Ϫ).
significant increase in the level of p58 versus G4/G1D (Fig. 2B,  compare lanes 8 and 10) . This finding suggests that inclusion of GIRK4 M1 in the G4/G1D chimera reduces the extent of Endo H-sensitive N-glycosylation in the contiguous GIRK1 region 108 -134, possibly by inducing an unfavorable conformation in this area required for this enzymatic modification in the rough endoplasmic reticulum. This may be a partial explanation for why GIRK4 is not N-glycosylated in this region even though it contains a putative N-glycosylation site. Interestingly, only G4/G1C-E heteromerized with endogenous p43 (Fig. 2, A and  B) , suggesting that the GIRK1 H5 pore region (Fig. 1B) , and not the GIRK4 H5 pore region, is required for this physical association. It was found that Phe 137 of GIRK1 is critical in conferring characteristic channel properties to heteromers with GIRK4 (31) . The size of ϳp70 was similar to the glycosylated GIRK1 in native atrial and brain tissues (65-72 kDa) (19, 33) , which suggests that it may represent a mature glycosylated channel in oocytes. Although ϳp70 intensity varied in different batches of oocytes, it appeared most prominent when the M1-M2 region belonged to the same subunit (Fig. 2, A, lanes 1  and 5; and B, lanes 2, 3, and 10 -13), and it was not detected in oocytes injected with only GIRK4 cRNA (data not shown and Ref. 21 ). The identity of ϳp70 will be discussed below.
GIRK1(N119Q) Protein Expression-GIRK1
has only one putative N-glycosylation site on the extracellular M1-M2 linker at Asn
119
. This site was mutated to GIRK1(N119Q), and its cRNA was expressed in oocytes to examine the pattern of protein processing versus control. G1-Ab-precipitated [
35 S]Met/ Cys-labeled membrane proteins from oocytes injected with GIRK1(N119Q) or wild-type cRNA were analyzed as described above. The nonglycosylated p56 was detected in oocytes injected with either cRNA (Fig. 3A, lanes 1-5) . In contrast, p58 was detected in oocytes injected with control, but not GIRK1(N119Q), cRNA (Fig. 3A, lanes 1 and 5 and lanes 2-4,  respectively) . Unexpectedly, the diffuse, somewhat smaller ϳp70 was also detected in oocytes injected with GIRK1(N119Q) cRNA (Fig. 3A, lanes 2-4) . p56 and p58 were expressed to higher levels versus ϳp70 in oocytes injected with wild-type cRNA (Fig. 3A, lanes 1 and 5) , and p56 was also expressed to a higher level versus ϳp70 in GIRK1(N119Q) cRNA-injected oocytes (lanes 2-4) . These results show that GIRK1 is N-glycosylated at Asn 119 in oocytes and that p58 contains a high mannose N-linked carbohydrate structure at this site. Obviously, if the GIRK1(N119Q) ϳp70 band is N-glycosylated, the site for this carbohydrate attachment is not Asn 119 . Expression of only GIRK1 resulted in appreciable N-glycosylation (Fig. 3A,  lane 5) , but endogenous oocyte GIRK4 expression and heteromeric formation may promote this (23, 45) .
Immunoblot analysis (Fig. 3B ), in agreement with the immunoprecipitation analysis (Fig. 3, A, C, and D) using G1-Ab, showed that the p58 band was not expressed by the GIRK1(N119Q) mutant. In contrast, the ϳp70 band was not detected in immunoblots of GIRK1(N119Q) when expressed alone or with GIRK4 (Fig. 3B, compare lanes 2 and 3 with lanes  1 and 4) , unlike the results from the immunoprecipitation analysis. Two possible interpretations for this difference are as follows: (a) the G1-Ab reactivity to the GIRK1 protein is conformation-dependent (G1-Ab precipitates the radiolabeled ϳp70 band directly, but does not bind it on an immunoblot); or (b) ϳp70 is not a GIRK1-modified protein, but a distinct tightly associated protein that coimmunoprecipitates in radiolabeled oocytes. Further work will be required to rigorously define the nature of ϳp70.
Endo H and PNGase F Treatment of GIRK4 and GIRK1 Proteins-PNGase F, which cleaves all N-linkages, was used to determine whether a channel protein band was N-glycosylated.
G1-Ab-precipitated [
35 S]Met/Cys-labeled membrane proteins from oocytes injected with G4/G1E, GIRK1, G4ϩG1, or G4ϩG1(N119Q) cRNA were treated with different glycosidases and analyzed as described above. As expected from our results shown in Fig. 2B , only p58 was sensitive to Endo H treatment in oocytes injected with G4/G1E, GIRK1, or G4ϩG1 cRNA (Fig.  3C, lanes 2, 5, and 8, respectively) , whereas no effect was detected on any protein bands from oocytes coinjected with G4ϩG1(N119Q) cRNA (lane 11). p58 was also sensitive to PNGase F digestion, as expected; but surprisingly, ϳp70 also appeared sensitive to this treatment in oocytes injected with the different cRNAs (Fig. 3C, lanes 3, 6, 9, and 12) . This result suggests that ϳp70 is an N-glycosylated glycoprotein. However the GIRK1(N119Q) protein and the G4/G1A-C proteins are not predicted to be N-glycosylated. If ϳp70 is N-glycosylated, the carbohydrate attachment site is not at a canonical consensus site. Although the possibility that ϳp70 is a channel aggregate cannot be rigorously excluded, it is rather unlikely because ϳp70 is sensitive to treatment by PNGase F.
Mutations of Possible Non-canonical Glycosylation Sites on GIRK1 and GIRK4 -GIRK1(N119Q) showed a ϳp70 band (Fig. 3A, lanes 2-4) , which was Endo F-sensitive (Fig. 3C, lane  12) . G4/G1A also showed a ϳp70 band (Fig. 2B, lanes 2 and 3) , but this chimera only has the GIRK4 extracellular linker between M1 and M2. Both of these ϳp70 bands were not predicted to be produced, although the bands are somewhat smaller than ϳp70 (Fig. 2B, compare lanes 2 and 3 with lanes  12 and 13; and Fig. 3A, compare lanes 4 and 5) . Might a non-canonical N-glycosylation site on the extracellular linker between M1 and M2 be responsible for some of the ϳp70 band? The mutants GIRK1(N126Q), GIRK1(N119Q/N126Q), and G4(N132Q)/G1A were constructed, and their cRNAs were injected into oocytes for radiolabeling and immunoprecipitation. Using the above constructs, we found no evidence that the mutated sites were responsible for the ϳp70 band (data not shown).
Assembly of G4ϩG1(N119Q) Heteromers-We next sought to determine whether glycosylation at Asn 119 affects the ability of GIRK1 to form heteromers with GIRK4. It has been shown that wild-type GIRK1 and GIRK4 expressed in oocytes physically associate by using reciprocal G1-Ab or G4-Ab precipitations (21) . Oocytes were coinjected with G4ϩG1(N119Q) or G4ϩG1 cRNA, [ 35 S]Met/Cys-labeled, and precipitated with either G1-Ab or G4-Ab, and then the proteins were analyzed as described above. The pattern and intensity of proteins precipitated by G1-Ab were similar, except that p58 was not detected in oocytes injected with G4ϩG1(N119Q) (Fig. 3D , compare lanes 4 and 6; also see Fig. 3C, compare lanes 7 and 10) . When G4-Ab was used for these precipitations, a similar protein pattern was detected, except that p58 was not detected in oocytes injected with G4ϩG1(N119Q) (Fig. 3D, compare lanes 3  and 5) . These results suggest that preventing N-glycosylation of GIRK1 at Asn 119 does not affect its ability to heteromerize with GIRK4.
Functional Analysis of the GIRK1(N119Q) Mutant-Does Nlinked glycosylation at Asn 119 of GIRK1 play a functional role? To address this question, we compared the biophysical properties and G protein gating of the glycosylation mutant GIRK1(N119Q) with those of the wild-type GIRK1 subunits as parts of heteromeric channels with GIRK4. The mean open time (Fig. 4A ) and the single-channel current amplitude (Fig. 4 , B and C) of heteromeric channels including GIRK1(N119Q) were indistinguishable from those of channels with wild-type subunits. Similarly, coexpression of GIRK1(N119Q) versus GIRK1 with GIRK4 and m2 muscarinic receptors yielded AChinduced currents of comparable magnitude (Fig. 5) .
Our study using the oocyte expression system showed that (a) GIRK1 is N-glycosylated at Asn 119 , whereas Asn 132 of GIRK4 is not; (b) GIRK1 M1 is required for optimal glycosylation at GIRK1 Asn 119 ; (c) there may be a non-canonical glycosylation site on GIRK1 responsible for ϳp70, but it is not GIRK1 Asn 126 ; and (d) Asn 119 glycosylation of GIRK1 does not affect its ability to form heteromers with GIRK4, its heteromer routing to the cell surface, or its biophysical channel properties or agonist-induced stimulation. In contrast, evidence suggested that glycosylation of ROMK1 at Asn 117 has significant functional effects. This mutation drastically reduces the magnitude of macroscopic currents due to a decrease in the channel open probability (4). Thus, N-glycosylation at similar positions on homologous inward rectifier K ϩ channels has different functional consequences.
